| Trial ID: | L3751 |
| Source ID: | NCT00335712
|
| Associated Drug: |
Ono-5129
|
| Title: |
Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: ONO-5129
|
| Outcome Measures: |
Primary: Fasting Blood Glucose at week 8 | Secondary: Other glycemic control parameters (e.g., HbA1c, glycoalbumin)
|
| Sponsor/Collaborators: |
Sponsor: Ono Pharma USA Inc
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
81
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-06
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2012-06-13
|
| Locations: |
Kanto Region, Kanto, Japan|Kyusyu Region, Kyusyu, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT00335712
|
